Original language | English |
---|---|
Pages (from-to) | e003553 |
Journal | Circulation. Genomic and precision medicine |
Volume | 15 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Feb 2022 |
Keywords
- cardiovascular diseases
- causality
- inflammation
- linear models
- neutrophils
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Circulation. Genomic and precision medicine, Vol. 15, No. 1, 01.02.2022, p. e003553.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Genetically Predicted Neutrophil-to-Lymphocyte Ratio and Coronary Artery Disease
T2 - Evidence From Mendelian Randomization
AU - Cupido, Arjen J.
AU - Kraaijenhof, Jordan M.
AU - Burgess, Stephen
AU - Asselbergs, Folkert W.
AU - Hovingh, G. Kees
AU - Gill, Dipender
N1 - Funding Information: Dr Hovingh has received funding from Regeneron, Aegerion, Amgen, AstraZeneca, Eli Lilly, Genzyme, Kowa, Pfizer, Regeneron Pharmaceuticals, Roche, Sanofi, The Medicines Company, and Ionis and is part-time employed by Novo Nordisk, Copenhagen, Denmark. Dr Gill is employed part-time by Novo Nordisk. The other authors report no conflicts. Funding Information: Dr Cupido reports grants from the Prince Bernhard Culture Fund and Stichting de Drie Lichten. Dr Burgess is supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (204623/Z/16/Z) and supported the National Institute for Health Research Cambridge Biomedical Research Centre (BRC-1215-20014). The views expressed are those of the authors and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. Dr Asselbergs is supported by University College London Hospitals National Institute for Health Research Biomedical Research Centre. Dr Hovingh reports research grants from the Netherlands Organization for Scientific Research (ViDi 016.156.445), het Klinkerpad fonds and the European Union (transcard). Dr Gill is supported by the British Heart Foundation Research Centre of Excellence (RE/18/4/34215) at Imperial College London and by a National Institute for Health Research Clinical Lectureship (CL-2020-16-001) at St. George's, University of London.
PY - 2022/2/1
Y1 - 2022/2/1
KW - cardiovascular diseases
KW - causality
KW - inflammation
KW - linear models
KW - neutrophils
UR - http://www.scopus.com/inward/record.url?scp=85124636564&partnerID=8YFLogxK
U2 - https://doi.org/10.1161/CIRCGEN.121.003553
DO - https://doi.org/10.1161/CIRCGEN.121.003553
M3 - Article
C2 - 35103484
SN - 2574-8300
VL - 15
SP - e003553
JO - Circulation. Genomic and precision medicine
JF - Circulation. Genomic and precision medicine
IS - 1
ER -